Overview

Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」

Status:
Completed
Trial end date:
2013-04-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to gain an understanding of the actual use of candesartan cilexetil (Blopress) in patients with hypertension, and to examine the changes in parameters such as blood pressure.
Details
Lead Sponsor:
Takeda
Treatments:
Candesartan
Candesartan cilexetil